Safety and immunogenicity of a recombinant receptor-binding domain-based protein subunit vaccine (Noora vaccine™) against COVID-19 in adults: A randomized, double-blind, placebo-controlled, Phase 1 trial

Jafar Salimian; Ali Ahmadi; Jafar Amani; Gholamreza Olad; Raheleh Halabian; Ali Saffaei; Masoud Arabfard; Mojtaba Nasiri; Shahram Nazarian; Hassan Abolghasemi; Gholamhossein Alishiri

Journal of Medical Virology (2023) - Comments
pubmed: 36029105 doi: 10.1002/jmv.28097 issn: 0146-6615 issn: 1096-9071

Jafar Salimian, Ali Ahmadi, Jafar Amani, Gholamreza Olad, Raheleh Halabian, Ali Saffaei, Masoud Arabfard, Mojtaba Nasiri, Shahram Nazarian, Hassan Abolghasemi, Gholamhossein Alishiri